Join AFTINETIs the RCEP the TPP by another name

Senior bureaucrat confirms no China FTA testing for local workers

September 9, 2015: The Prime Minister's claim in Parliament that  the China FTA allows " no possibility of placing any foreigner in an Australian job without labour market testing"  was flatly contradicted by the evidence of a senior officer from  Department of Immigration and Border Protection to the Joint Standing Committee on Treaties on September 7 .

Shorten criticism of China FTA backed by academics

September 3, 2015: the Sydney Morning Herald reports that ALP Opposition Leader Bill Shorten is sticking to his criticism that China FTA does not require testing for local workers for projects over $150 million, despite government denials. Associate Prof Stuart Rosewarne and migration law expert Joanne Howe writing in The Drum agree with this criticism after analysing both the text of the agreement and the government’s response.

150 Health experts say no TPP tradeoffs on medicines, investor rights

Over one hundred and fifty senior Australian academics and others with expertise in public health and medicine have called on Trade Minister Andrew Robb to remain firm in his resolve to protect health and the environment in negotiations on the Trans Pacific Partnership Agreement (TPPA).

The letter was initiated by the Public Health Association of Australia (PHAA) following concerns that some of the gains made by the Minister could be traded for sugar or some other commodity. see the media release here

Leaked TPP draft confirms US push on medicines: Australia should resist at August meeting

'A leaked draft TPP intellectual property chapter dated 11 May 2015, confirms that the US is still proposing extensions on medicine monopolies which would delay the availability of cheaper medicines. The draft was considered at the meeting of TPP Trade Ministers which failed to reach agreement on July 31,” Dr Patricia Ranald, Coordinator of the Australian Fair Trade and Investment Network said today.Dr Ranald said that another meeting is planned by the end of August. The US is continuing to press for:extension of data protection monopolies on expensive biologic drugs, which include treatments for cancer, from 5 to 8 years.